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Hippocampal regional differences in un-medicated patients with first episode psychosis
Purpose
• Schizophrenic patients have been found to have altered brain 
structures with many regions having reduced volumes when 
compared to their healthy counterparts. 
• Recent research suggests that schizophrenic individuals have 
reduced grey matter volumes in the frontal lobes, subcortical and 
limbic region (Birur et al., 2017).  
• However, the hippocampal responsibility for memory and spatial 
recognition make it the current focus for schizophrenia research. 
• Present research suggests a negative correlation between 
hippocampal volume and severity of negative symptoms as well as 
a significant overall decrease in hippocampal volume in individuals 
with schizophrenia (Bartholomeusz et al., 2017; Birur et al., 2017; 
Kalmady et al., 2017; Walter et al., 2016).
• It is believed that there are regional differences in hippocampal 
reductions because each region projections to various other 
neuroanatomical structures, suggesting different functionality 
(Kalmady et al., 2017). 
• The results suggest there are volume changes in anterior 
regions of the hippocampus in individuals with 
schizophrenia as is reflected in the literature. 
• The results also suggest these changes are due to the disease 
rather than as an effect of medication.
• Further work is needed understand how these regional 
volume differences relate to symptoms experienced by 
individuals with schizophrenia. 
Methods
• In the present study 27 participants were recruited from the Centre 
for Addiction and Mental Health in Toronto. 
• Participants had an average age of 26.7 years (SD = 5.9 years).
• Participants belonged to one of three groups, healthy control, 
clinical high risk or un-medicated first episode psychosis patients 
with schizophrenia. 
• Anatomical Magnetic Resonance Imaging (MRI) data was 
acquired for each study participant (following informed consent). 
• Cognitive and psychological data were also collected to correlate 
with neuroanatomical changes:
 Positive and negative symptom scale (PANSS): to quantify 
symptoms
 Wisconsin Sorting Task (WCST): Frontal lobe functioning (ie. 
Abstract thinking, attention, memory etc.)
 Repeatable Battery for the Assessment of Neuropsychological 
Status (RBANS): To assess memory, attention and language
• The hippocampus from each scan was segmented using 
Freesurfer’s hippocampal automatic segmentation program into 
eleven subfields. 
• A repeated measures ANOVA was used to compare the gray 
matter of each subfield between patient group and control group 
controlling for age and sex to determine if any regional volume 
reductions are present. 
Results
• ** Initial findings indicate a significant difference of size 
between groups in the Hippocampus Amygdala Transition 
Area (HATA) (p =0.04) as well as a left side increase in the 
HATA region (p = 0.002).
• # A significant main effect of sex difference in the CA2/CA3 
region was observed (p = 0.037).
• These findings are consistent with current literature (Haukvik
et al,2015; Ho et al., 2017; Mathew et al., 2014; Ota et al., 
2017). 
• However, normative men compared to men with 
schizophrenia and normative women compared to women 
with schizophrenia were both non-significant (p = 0.055, p = 
0.482).
• Weak to moderate correlations (p<0.05) were found between 
CA2/CA3 region and some aspects of WCST (r=0.52 to r=-
0.46) and HATA and RBANS Attention (r=-0.44) and 
CA2/CA3 RBANS visuospatial memory (r=0.42).
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PANSS Positive Negative General
HATA .02 .04 .13
CA2/CA3 -.27 .15 .23






HATA -.12 .11 -.17 -.44 -.12
CA2/CA3 .19 .42 .24 -.37 .20








HATA .12 -.07 -.16 -.20 -.21
CA2/CA3 .52 .00 -.46 -.31 -.38
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